NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









HaploX

HaploX

Private
ShenzhenHealthcare & Life Scienceshttps://www.haplox.cn/

Last Round

Series D

Jul 25, 2022

Est. Valuation

$430M

Total Funding Raised

$86.22M

Company Overview

HaploX is a biotechnology company that provides genetic testing solutions, specializing in gene sequencing, liquid biopsies, and bioinformatics for cancer diagnostics and health screening.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Hardware Sales, Data as a Service

AI Layer

Application

Keywords

liquid biopsycancer diagnosticsnext-generation sequencingNGSminimal residual diseaseMRDprecision oncologycompanion diagnosticsCDxin vitro diagnosticsIVDcirculating tumor DNActDNAbioinformaticsCRO servicesgenomic analysismulti-omicsgenetic testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HaploX Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

HaploX Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DJul 25, 2022
Series CJul 1, 2021
Series B ExtensionApr 1, 2020
Series BJun 28, 2018
Series A ExtensionDec 28, 2017
Series A
May 16, 2016

HaploX Investors

Notable investors and investment history

InvestorRounds
Efung CapitalSeries B
CNCB (Hong Kong) Investment LimitedSeries D
SB China CapitalSeries A Extension, Series D, Series A
Shenzhen Investment Holdings Co., Ltd.Series B Extension
Mingjia CapitalSeries C
Shenzhen Capital GroupSeries B

HaploX Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HaploX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HaploX's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Employee Range31
Year Founded2014
Last FundingJul 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.